<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>The Medical Xchange</provider_name><provider_url>https://themedicalxchange.com/en/</provider_url><title>Concrete Steps Taken to Base Severe Asthma Treatment on Molecular Rather than Clinical Phenotypes - The Medical Xchange</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="dQqW0Mkfn3"&gt;&lt;a href="https://themedicalxchange.com/en/2015/10/07/european-respiratory-society-ers-international-con/"&gt;Concrete Steps Taken to Base Severe Asthma Treatment on Molecular Rather than Clinical Phenotypes&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://themedicalxchange.com/en/2015/10/07/european-respiratory-society-ers-international-con/embed/#?secret=dQqW0Mkfn3" width="600" height="338" title="&#x201C;Concrete Steps Taken to Base Severe Asthma Treatment on Molecular Rather than Clinical Phenotypes&#x201D; &#x2014; The Medical Xchange" data-secret="dQqW0Mkfn3" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://themedicalxchange.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://themedicalxchange.com/wp-content/uploads/2015/10/2356_ERS_2015_EN_Table_1.PNG</thumbnail_url><thumbnail_width>960</thumbnail_width><thumbnail_height>720</thumbnail_height><description>Amsterdam &#x2013; Subgrouping patients according to immune cell composition in the sputum is expected to revolutionize management of severe asthma, according to a series of studies presented at the ERS International Congress 2015. Asthma has long been understood as a heterogeneous condition, but there has been recent progress in using sputum to subgroup patients by molecular phenotype for treatment selection. One study suggested the inflammatory cell composition in sputum might direct treatment choice, while two late breaker studies with novel agents found blood and sputum eosinophil counts to be a predictor of response.</description></oembed>
